These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
190 related items for PubMed ID: 25209879
1. Initial serum ferritin predicts number of therapeutic phlebotomies to iron depletion in secondary iron overload. Panch SR, Yau YY, West K, Diggs K, Sweigart T, Leitman SF. Transfusion; 2015 Mar; 55(3):611-22. PubMed ID: 25209879 [Abstract] [Full Text] [Related]
2. Efficacy and safety of phlebotomy to reduce transfusional iron overload in adult, long-term survivors of acute leukemia. Franchini M, Gandini G, Veneri D, de Matteis G, Federici F, Solero P, Aprili G. Transfusion; 2004 Jun; 44(6):833-7. PubMed ID: 15157247 [Abstract] [Full Text] [Related]
3. Rusfertide for the treatment of iron overload in HFE-related haemochromatosis: an open-label, multicentre, proof-of-concept phase 2 trial. Kowdley KV, Modi NB, Peltekian K, Vierling JM, Ferris C, Valone FH, Gupta S. Lancet Gastroenterol Hepatol; 2023 Dec; 8(12):1118-1128. PubMed ID: 37863080 [Abstract] [Full Text] [Related]
4. Iron overload in patients receiving allogeneic hematopoietic stem cell transplantation: quantification of iron burden by a superconducting quantum interference device (SQUID) and therapeutic effectiveness of phlebotomy. Busca A, Falda M, Manzini P, D'Antico S, Valfrè A, Locatelli F, Calabrese R, Chiappella A, D'Ardia S, Longo F, Piga A. Biol Blood Marrow Transplant; 2010 Jan; 16(1):115-22. PubMed ID: 19766730 [Abstract] [Full Text] [Related]
5. Phlebotomy to reduce iron overload in patients cured of thalassemia by bone marrow transplantation. Italian Cooperative Group for Phlebotomy Treatment of Transplanted Thalassemia Patients. Angelucci E, Muretto P, Lucarelli G, Ripalti M, Baronciani D, Erer B, Galimberti M, Giardini C, Gaziev D, Polchi P. Blood; 1997 Aug 01; 90(3):994-8. PubMed ID: 9242528 [Abstract] [Full Text] [Related]
6. Clinical and Laboratory Associations with Persistent Hyperferritinemia in 373 Black Hemochromatosis and Iron Overload Screening Study Participants. Barton JC, Barton JC, Adams PC. Ann Hepatol; 2017 Aug 01; 16(5):802-811. PubMed ID: 28809726 [Abstract] [Full Text] [Related]
7. A prospective study of iron overload management in allogeneic hematopoietic cell transplantation survivors. Majhail NS, Lazarus HM, Burns LJ. Biol Blood Marrow Transplant; 2010 Jun 01; 16(6):832-7. PubMed ID: 20079863 [Abstract] [Full Text] [Related]
8. Iron overload manifesting as apparent exacerbation of hepatic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Kamble RT, Selby GB, Mims M, Kharfan-Dabaja MA, Ozer H, George JN. Biol Blood Marrow Transplant; 2006 May 01; 12(5):506-10. PubMed ID: 16635785 [Abstract] [Full Text] [Related]
9. Generalized pruritus in dysmetabolic hyperferritinemia treated by phlebotomy. Brigant F, Hautefeuille V, Dadban A, Lok C, Nguyen-Khac E, Chaby G. Dermatol Online J; 2015 Sep 17; 21(9):. PubMed ID: 26437295 [Abstract] [Full Text] [Related]
11. An assessment of iron overload in children treated for cancer and nonmalignant hematologic disorders. Rascon J, Rageliene L, Stankeviciene S, Palionis D, Tamosiunas AE, Valeviciene N, Zvirblis T. Eur J Pediatr; 2014 Sep 17; 173(9):1137-46. PubMed ID: 24659311 [Abstract] [Full Text] [Related]
12. [Comparison between phlebotomy and erythrocytapheresis of iron overload in patients with HFE gene mutations]. Fernández-Mosteirín N, Salvador-Osuna C, García-Erce JA, Orna E, Pérez-Lungmus G, Giralt M. Med Clin (Barc); 2006 Sep 23; 127(11):409-12. PubMed ID: 17020684 [Abstract] [Full Text] [Related]
13. Iron overload in hematopoietic cell transplantation. Majhail NS, Lazarus HM, Burns LJ. Bone Marrow Transplant; 2008 Jun 23; 41(12):997-1003. PubMed ID: 18438425 [Abstract] [Full Text] [Related]
14. Hyperferritinemia after adult allogeneic hematopoietic cell transplantation: quantification of iron burden by determining non-transferrin-bound iron. Goto T, Ikuta K, Inamoto Y, Kamoshita S, Yokohata E, Koyama D, Onodera K, Seto A, Watanabe K, Imahashi N, Tsukamoto S, Ozawa Y, Sasaki K, Ito M, Kohgo Y, Miyamura K. Int J Hematol; 2013 Jan 23; 97(1):125-34. PubMed ID: 23264147 [Abstract] [Full Text] [Related]
16. Effect of phlebotomy on lipid metabolism in subjects with hereditary hemochromatosis. Casanova-Esteban P, Guiral N, Andrés E, Gonzalvo C, Mateo-Gallego R, Giraldo P, Paramo JA, Civeira F. Metabolism; 2011 Jun 23; 60(6):830-4. PubMed ID: 20846699 [Abstract] [Full Text] [Related]
17. One-year results from a prospective randomized trial comparing phlebotomy with deferasirox for the treatment of iron overload in pediatric patients with thalassemia major following curative stem cell transplantation. Inati A, Kahale M, Sbeiti N, Cappellini MD, Taher AT, Koussa S, Nasr TA, Musallam KM, Abbas HA, Porter JB. Pediatr Blood Cancer; 2017 Jan 23; 64(1):188-196. PubMed ID: 27576370 [Abstract] [Full Text] [Related]
18. Patient compliance with phlebotomy therapy for iron overload associated with hemochromatosis. Hicken BL, Tucker DC, Barton JC. Am J Gastroenterol; 2003 Sep 23; 98(9):2072-7. PubMed ID: 14499790 [Abstract] [Full Text] [Related]
19. Metabolic and hepatic effects of bloodletting in dysmetabolic iron overload syndrome: A randomized controlled study in 274 patients. Lainé F, Ruivard M, Loustaud-Ratti V, Bonnet F, Calès P, Bardou-Jacquet E, Sacher-Huvelin S, Causse X, Beusnel C, Renault A, Bellissant E, Deugnier Y, Study Group. Hepatology; 2017 Feb 23; 65(2):465-474. PubMed ID: 27685251 [Abstract] [Full Text] [Related]
20. Efficacy of repeated phlebotomies in hypertriglyceridemia and iron overload: A prospective, randomized, controlled trial. Mateo-Gallego R, Lacalle L, Pérez-Calahorra S, Marco-Benedí V, Recasens V, Padrón N, Lamiquiz-Moneo I, Baila-Rueda L, Jarauta E, Calmarza P, Cenarro A, Civeira F. J Clin Lipidol; 2018 Feb 23; 12(5):1190-1198. PubMed ID: 30049591 [Abstract] [Full Text] [Related] Page: [Next] [New Search]